In another breaking story from the UK, a company called Angle PLC has announced that its Parsortix diagnostic system can potentially be used to identify men with prostate cancer using a simple blood sample and testing for the presence of circulating tumor cells (CTCs). … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Angle, cell, circulating, CTC, Diagnosis, Parsortix, risk, tumor | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 